Evidence map›Paper›PMID 27829403›Full record

ArticleBMC pulmonary medicine2016

Longitudinal trends in clinical characteristics and lung function of patients with severe asthma under treatment in Brazil.

P C A Almeida, E V Ponte, A Souza-Machado, A A Cruz

Open access · goldAbstract read
In one paragraph

Article in BMC pulmonary medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Future Risks in Patients With Severe Asthma.Allergy, asthma & immunology research · 2019
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

P C A AlmeidaProAR - Center of Excellence for Asthma of Federal University of Bahia (UFBA), Salvador, Brazil. fisioterapia.proar@gmail.com.
E V PonteFaculdade de Medicina de Jundiaí, São Paulo, Brazil.
A Souza-MachadoInstitute for Health Sciences of UFBA and Coordinator of ProAR, Salvador, Brazil.
A A CruzCenter of Excellence for Asthma of UFBA, Salvador, Brazil.
Faculdade de Medicina de Jundiaí · BRUniversidade Federal da Bahia · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe structural changes of the respiratory system related to ageing determine lung function decline in healthy subjects after 25 years of age. An annual reduction of 25 ml in Forced Expiratory Volume in 1 s (FEV1) is expected. We aimed to describe the longitudinal lung function variation of subjects with severe asthma receiving appropriate treatment.

methodsConsecutive patients enrolled in a Brazilian reference clinic between 2003 and 2006 were invited to participate. The study participants were followed up for a median of 8 years, and were evaluated with spirometry in three distinct occasions (V0, V1 and V8), at least. At V0, upon enrollment, subjects with previous severe untreated asthma were evaluated by a specialist, had their health resource utilization in the last 12 months recorded, and performed spirometry. In V1, 1 year after V0, under proper management, subjects repeated the procedures and answered the Asthma Control Questionnaire (ACQ) and the Asthma Quality of Life Questionnaire (AQLQ). In the last study visit (V8), 7 years after V1, all patients underwent a pre and post-broncodilator (postBD) spirometry, skin prick test for aeroallergens, answered the ACQ and the AQLQ and had another interview with the specialist.

resultsTwo hundred thirty-four subjects were followed up between V0 and V8. A comparison between spirometries of V1 and V8, after the initial improvement has supposedly reached a plateau, shows that the FEV

conclusionsCurrently available treatment with a combination of inhaled corticosteroids and LABA may not be sufficient to prevent lung function decline in subjects with severe asthma.

Indexed as

Administration, InhalationAdrenal Cortex HormonesAdultAllergensAsthmaBrazilFemaleForced Expiratory VolumeHumansLongitudinal StudiesMaleMiddle AgedProspective StudiesQuality of LifeSkin TestsSpirometryAdrenal Cortex HormonesAllergensAsthmaLongitudinal studiesPulmonary diseaseSpirometry

Identifiers

PMID27829403
PMCPMC5103442
OpenAlexW2552462053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.